Found: 26
Select item for more details and to access through your institution.
The effect of infliximab in patients with chronic low back pain and Modic changes (the BackToBasic study): study protocol of a randomized, double blind, placebo-controlled, multicenter trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Heterophilic antibody interference in commercial immunoassays; a screening study using paired native and pre-blocked sera.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2011, v. 49, n. 12, p. 2001, doi. 10.1515/CCLM.2011.702
- By:
- Publication type:
- Article
Perinatal Asphyxia May Influence the Level of Beta-Amyloid (1-42) in Cerebrospinal Fluid: An Experimental Study on Newborn Pigs.
- Published in:
- PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0140966
- By:
- Publication type:
- Article
Exploratory Analysis of CA125-MGL and --STn Glycoforms in the Differential Diagnostics of Pelvic Masses.
- Published in:
- Journal of Applied Laboratory Medicine, 2020, v. 5, n. 2, p. 263, doi. 10.1093/jalm/jfz012
- By:
- Publication type:
- Article
Renal Function Influences Diagnostic Markers in Serum and Urine: A Study of Guanidinoacetate, Creatine, Human Epididymis Protein 4, and Neutrophil Gelatinase--Associated Lipocalin in Children.
- Published in:
- Journal of Applied Laboratory Medicine, 2017, p. 297, doi. 10.1373/jalm.2016.022145
- By:
- Publication type:
- Article
Belief is only half the truth - or why screening for heterophilic antibody interference in certain assays makes double sense.
- Published in:
- Annals of Clinical Biochemistry, 2012, v. 49, n. 4, p. 381, doi. 10.1258/acb.2012.011228
- By:
- Publication type:
- Article
Maternal placental growth factor and soluble fms-like tyrosine kinase-1 reference ranges in post-term pregnancies: A prospective observational study.
- Published in:
- PLoS ONE, 2020, v. 15, n. 10, p. 1, doi. 10.1371/journal.pone.0240473
- By:
- Publication type:
- Article
A Man with Abdominal Pain: Enough Evidence for Surgery?
- Published in:
- Clinical Chemistry, 2012, v. 58, n. 8, p. 1187, doi. 10.1373/clinchem.2011.167015
- By:
- Publication type:
- Article
HLA‐DQ2 is associated with anti‐drug antibody formation to infliximab in patients with immune‐mediated inflammatory diseases.
- Published in:
- Journal of Internal Medicine, 2023, v. 293, n. 5, p. 648, doi. 10.1111/joim.13616
- By:
- Publication type:
- Article
Risk factors for anti‐drug antibody formation to infliximab: Secondary analyses of a randomised controlled trial.
- Published in:
- Journal of Internal Medicine, 2022, v. 292, n. 3, p. 477, doi. 10.1111/joim.13495
- By:
- Publication type:
- Article
Adalimumab serum levels and anti-drug antibodies: associations to treatment response and drug survival in inflammatory joint diseases.
- Published in:
- Rheumatology, 2024, v. 63, n. 6, p. 1746, doi. 10.1093/rheumatology/kead525
- By:
- Publication type:
- Article
Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcome.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Subcutaneous Vedolizumab Treatment in a Real-World Inflammatory Bowel Disease Cohort Switched From Intravenous Vedolizumab: Eighteen-Month Prospective Follow-up Study.
- Published in:
- Crohn's & Colitis 360, 2024, v. 6, n. 1, p. 1, doi. 10.1093/crocol/otae013
- By:
- Publication type:
- Article
Pro‐gastrin‐releasing peptide and outcome in patients with heart failure and anaemia: results from the RED‐HF study.
- Published in:
- ESC Heart Failure, 2018, v. 5, n. 6, p. 1052, doi. 10.1002/ehf2.12312
- By:
- Publication type:
- Article
Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction in Patients With Chronic Immune-Mediated Inflammatory Diseases-Reply.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Cerebrospinal Fluid S100B and Alzheimer’s Disease Biomarkers in Hip Fracture Patients with Delirium.
- Published in:
- Dementia & Geriatric Cognitive Disorders Extra, 2017, v. 7, n. 3, p. 374, doi. 10.1159/000481853
- By:
- Publication type:
- Article
Therapeutic drug monitoring of infliximab compared to standard clinical treatment with infliximab: study protocol for a randomised, controlled, open, parallel-group, phase IV study (the NOR-DRUM study).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Rheumatoid factor and falsely elevated results in commercial immunoassays: data from an early arthritis cohort.
- Published in:
- Rheumatology International, 2021, v. 41, n. 9, p. 1657, doi. 10.1007/s00296-021-04865-9
- By:
- Publication type:
- Article
Associations between certolizumab pegol serum levels, anti-drug antibodies and treatment response in patients with inflammatory joint diseases: data from the NOR-DMARD study.
- Published in:
- Arthritis Research & Therapy, 2019, v. 21, n. 1, p. N.PAG, doi. 10.1186/s13075-019-2009-5
- By:
- Publication type:
- Article
Subtherapeutic concentrations of infliximab and adalimumab are associated with increased disease activity in Crohn's disease.
- Published in:
- Therapeutic Advances in Gastroenterology, 2018, v. 11, p. 1, doi. 10.1177/1756284818759930
- By:
- Publication type:
- Article
Determination of lower cut‐off levels of adalimumab associated with biochemical remission in Crohn's disease.
- Published in:
- JGH Open, 2020, v. 4, n. 3, p. 410, doi. 10.1002/jgh3.12266
- By:
- Publication type:
- Article
Therapeutic Drug Monitoring: A Tool to Optimize Treatment of Inflammatory Joint Diseases.
- Published in:
- Arthritis & Rheumatology, 2024, v. 76, n. 5, p. 667, doi. 10.1002/art.42764
- By:
- Publication type:
- Article
Assessing Immunogenicity of Biologic Drugs in Inflammatory Joint Diseases: Progress Towards Personalized Medicine.
- Published in:
- BioDrugs, 2022, v. 36, n. 6, p. 731, doi. 10.1007/s40259-022-00559-1
- By:
- Publication type:
- Article
Efficacy and Safety of CT-P13 in Inflammatory Bowel Disease after Switching from Originator Infliximab: Exploratory Analyses from the NOR-SWITCH Main and Extension Trials.
- Published in:
- BioDrugs, 2020, v. 34, n. 5, p. 681, doi. 10.1007/s40259-020-00438-7
- By:
- Publication type:
- Article
Falsely markedly elevated 25-hydroxyvitamin D in patients with monoclonal gammopathies.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2021, v. 59, n. 4, p. 663, doi. 10.1515/cclm-2020-1411
- By:
- Publication type:
- Article
KJELL JOHANNES NUSTAD.
- Published in:
- Journal of the Norwegian Medical Association / Tidsskrift for Den Norske Laegeforening, 2020, v. 140, n. 11, p. 1184
- By:
- Publication type:
- Article